Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BLINATUMOMAB vs BORTEZOMIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BLINATUMOMAB vs BORTEZOMIB: Safety Overview

Metric BLINATUMOMAB BORTEZOMIB
Total FAERS Reports 9,161 47,710
Deaths Reported 1,664 7,318
Death Rate 18.2% 15.3%
Hospitalizations 2,427 14,626
Average Patient Age 39.7 yrs 64.1 yrs
% Female Patients 46.7% 44.5%
FDA Approval Date N/A Aug 26, 2024
Manufacturer Amgen, Inc Hikma Pharmaceuticals USA Inc.
Route N/A INTRAVENOUS
Marketing Status Prescription Prescription